Semler Scientific Corp (SMLR) - Long-Term Indebtedness

Symbol and logo of brand Semler (SMLR)

This price chart for Semler Scientific, Inc. (SMLR) illustrates the performance of a company expanding its network of active sales agents to deploy vascular analysis systems through an unlimited bonus structure. Meanwhile, long-term debt stands at 0.00. Financial risks stem from a narrow product portfolio and the potential revision of insurance reimbursements. Further instability is introduced by the company's bet on cryptocurrency assets, which has overshadowed its primary medical business profile.

SMLR (Semler Scientific Corp) Company Long-Term Debt history from 07/04/2022 to 01/31/2026

Metric breakdowns and analytics for Semler Scientific Corp (SMLR)

- price and consensus price forecast:
Stock Price semlerscientific.com|SMLR - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Semler Scientific|SMLR - Total Company Value
- book capitalization data:
Equity per Share Semler Scientific|SMLR - Company Book Value|Market-to-Book Ratio semlerscientific.com|SMLR - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Semler Scientific, Inc.|SMLR - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Semler|SMLR - Company Aggregate Debts|Debts to Net Assets Semler Scientific|SMLR - Company Long-Term Debts|Company Current Liabilities Semler Scientific
General company analysis:SMLR (semlerscientific.com)
Mass-produced product of Semler Scientific Inc

Semler Scientific, Inc. (SMLR) is developing a network of cloud IT solutions for the diagnosis of vascular pathologies in US clinics. Rising capital expenditures on infrastructure are reflected in the dynamics of long-term liabilities, which measure the total volume of loans with maturities exceeding one year. This metric determines the level of financial leverage and the business's resilience to interest rates. Analyzing the corporation's volume of long-term loans and borrowings allows for an assessment of the risk of balance sheet overload during expansion.

Competitor analysis for Semler Scientific, Inc.

Company Long-Term Debts abbott.com ABT|Company Long-Term Debts TMO|GEHC: Long-Term Indebtedness|Company Long-Term Debt Mettler-Toledo International Inc.|WAT (Waters Technologies) - Company Long-Term Indebtedness|Company Long-Term Debt TECH (Bio-Techne Corporation)|Long-Term Debt BRKR|AZTA (Azenta) - Company Long-Term Debt|Long-Term Debt Volume Varex Imaging Corp VREX|Company Long-Term Liabilities Butterfly iQ (BFLY)|Amount of Long-Term Liabilities Mesa Laboratories Corp. MLAB|Company Long-Term Debts QSI (Quantum-Si)|NNOX - Long-Term Debt Volume|QTRX (Quanterix) - Company Long-Term Debts|Company Long-Term Liabilities 908 Devices Inc|CV - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings MXCT|Company Long-Term Debt RPID (Rapid Micro Biosystems)|Company Long-Term Liabilities seer.bio (SEER)|HYPR: Company Long-Term Debts|Long-Term Debt FONAR Corp. FONR|Daxor Corp. (DXR) - Company Long-Term Debts|MDAI - Company Long-Term Indebtedness|organovo.com - Company Long-Term Debts|aclarion.com (ACON) - Long-Term Debt Volume|Company Long-Term Debts AKYA|Company Long-Term Liabilities ThermoGenesis Holdings, Inc.|Company Long-Term Debts TLIS|Company Long-Term Debts TTOO (T2 Biosystems Inc)